Polyrizon

Innovative Intranasal Products

Health Tech & Life Sciences
Active
Public Ra'anana Founded 2020
Total raised
$27.0M
Last: PIPE 2026-04
Stage
Public
Founded
2020
Headcount
8
HQ
Ra'anana
Sector
Health Tech & Life Sciences

About

Polyrizon is a biotech company focused on the development and commercialization of innovative intranasal products.

Polyrizons Capture & Contain (C&C) platform is based on a natural 3D polymeric network tailored to optimally adhere to the nasal mucosal surface. The polymeric network creates a physical barrier that captures and contains biological contaminants, preventing their penetration. The C&C platform can be readily adapted for a wide range of applications to protect the human body from airborne contaminants such as allergens, viruses, and molds.

The companys Trap & Target (T&T) platform delivery technology is designed to allow a long residence time and intimate contact with the mucosal tissue for highly effective targeted delivery of medicines. It can be tailored to address the specific requirements of different molecules for improved therapeutic effect.

Funding history · 8 rounds · $27.0M total

2026-04
PIPE $3.5M
2025-03
PIPE $17.0M
2023-06
Seed $400K
2023-01
Seed $180K
2022-05
Seed $718K
2021-08
Seed $780K
2020-11
Undisclosed $150K
2020-03
Undisclosed $100K

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug Delivery
Target customers
Healthcare & Life SciencesMedical Devices IndustryMedical ProductsHealthcareProvidersPatientsLife SciencesPharmaceuticals
Business model
B2B2C

Highlights

1 PatentsVerified

Tags

allergybiopharmaceuticalbiotechnologypharmaceuticalsbiomaterialspolymerstopical-treatmentpharma-companies